Geriatrics and Pharmacology for Primary Care

Geriatrics and Pharmacology for Primary Care – 12 Credits

Overview
This conference is designed to provide primary care clinicians with up-to-date, evidence-based information on commonly encountered issues in Geriatrics and Pharmacology for Primary Care, while suggesting pragmatic approaches to clinical management. The discussion-based format of the conference will encourage audience participation through dynamic lectures, case-based studies, and hands-on workshops. Keynote speakers will present and critically assess recent advancements and industry updates in Geriatrics and Pharmacology with the goal of enhancing the knowledge-base and core competence of attendees. The successful completion of this interactive program diagnosing, treating, and prescribing the most effective courses of treatment, with the ultimate goal of improving patient outcomes.

Target Audience
All Physicians and other Healthcare Professionals seeking clinical information about issues in Geriatrics and Pharmacology for Primary Care.

Topics and Objectives

Geriatrics 

What is Geropalliative Medicine and Why Should we Integrate it into all Specialties?|
Objectives: 1) Attendees should be able to define the term geropalliative medicine. 2) Define the changing paradigm in measuring patient outcomes 3) Name the 6 domains to evaluate geropalliative outcomes

Geriatric Frailty Syndrome
Objectives: 1) Attendees should be able to define frailty 2) Discuss how frailty changes the course of patient outcomes 3) Name 3 physiologic signs you could use to help decide that a patient may be frail.

Why Didn’t Someone Warn Us?
Objectives: 1) Name 3 geriatric syndromes we should all be evaluating in daily clinical practice.2) Discuss how to refine your prognostic abilities using clinical signs. 3) Define why you can warn patients and families of unintended outcomes and why the patient is at higher risk.

Delirium 1
Objectives: 1) Name 3 types of delirium 2) Discuss what hospital induced delirium tells you about the patient’s future risk 3) Define ACB score and why it is important

Evidence Based Medical Prognostication
Objectives: 1) Define the 3 types of prognostic information we share with patients 2) Discuss the importance of defining individual risk in decision making and program development 3) Define how community-based palliative and at-home program can use prognosis to define it’s patient population.

Delirium 2
Objectives: 1) Name 3 harms of putting an elderly person to bed 2) Name non-medication tools to prevent delirium 3) Name 3 things you can do by eliminating or adding medications to prevent delirium.

Pharmacology

Alphabet Soup Part 1: Pharmacotherapy Updates in Lipid Management: Focus on the High Risk Patient
Objectives: 1) Summarize recommendations from clinical practice guidelines regarding lipid-lowering therapy 2) Discuss medication optimization for secondary prevention patients 3) Develop a therapeutic plan for a patient with complex lipid lowering needs 

Alphabet Soup Part Three: Hypertension Medication Management in Primary Care
Objectives: 1) Summarize recommendations from clinical practice guidelines regarding hypertension 2) Discuss evidence-based optimization for antihypertensives 3) Develop a therapeutic plan for a patient with resistant hypertension  

“First Comes Metformin, and Then Comes…?” Evaluating the Role of Oral Agents for Type 2 Diabetes
Objectives: 1) Summarize recommendations from clinical practice guidelines regarding diabetes 2) Discuss clinical evidence and place in therapy for newly approved oral diabetes agents 3) Develop a therapeutic plan for a patient with diabetes  

Injectable Products for Diabetes, Part One
Objectives: 1) Summarize recommendations from clinical practice guidelines regarding diabetes 2) Discuss clinical evidence and place in therapy for GLP-1 agonists 3) Develop a therapeutic plan for a patient with diabetes  

Injectable Products for Diabetes, Part Two: The Ins and Outs of Insulin
Objectives: 1) Summarize recommendations from clinical practice guidelines regarding diabetes 2) Discuss clinical evidence and place in therapy for newly approved insulin products 3) Develop a therapeutic plan for a patient with diabetes 

Note: Content is subject to change without notice. Please refer to the activity website for the most current information.